Dosing Music for Anxiety Reduction in Parturients
Estimating the Effective Dose of Music Duration for Anxiety Reduction Prior to Cesarean Delivery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Dan Drzymalski, MD
- Phone Number: 617-913-8168
- Email: ddrzymalski@tuftsmedicalcenter.org
Study Contact Backup
- Name: Tristan Fong, BS
- Email: tristan.fong@tufts.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Tufts Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 years or older
- Planning on scheduled cesarean section or non-emergent unscheduled cesarean section
- Able to provide informed consent
- American Society of Anaesthesiologists (ASA) physical status score of II-III
Exclusion Criteria:
- Patient refusal
- Impaired hearing
- Patient is taking at least one anxiolytic medication daily at baseline
- No anxiety (a score of 0, on a scale of 0-10, of pre-music exposure anxiety) after consent is given
- ASA IV or higher
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Mozart
Subjects in this arm will listen to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.
|
Music will be played from a speaker connected to a media-playing device for participants to listen to for set durations of time.
Music will be selections by Mozart of previously studied and shown to reduce anxiety.
|
|
Active Comparator: Patient preference
Subjects in this arm will listen to music from a list of pre-selected pieces of their own choosing.
|
Music will be played from a speaker connected to a media-playing device for participants to listen to for set durations of time.
Music will be selections of patient choice.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety Score
Time Frame: 4-8 minutes
|
Verbally rated anxiety on numeric rating scale (NRS) of 0-10, before and after intervention.
A rating of 0 meant the patient had no anxiety, while a rating of 10 meant the patient had the worst anxiety possible.
Must have been at least a 1-point decrease between pre- and post-intervention scores to be considered a positive response, larger decrease meant a better outcome.
|
4-8 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
STAI
Time Frame: 4-8 minutes
|
6-question abbreviated state-trait anxiety inventory (STAI) questions asked and scored on a 6-24 point scale (higher is more anxiety) for before and after intervention.
Decrease in score after intervention was considered a positive response, with larger decreases indicating better responses.
|
4-8 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Dan Drzymalski, MD, Tufts Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 00003958
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.